Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures

NCT01145599 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 374

Last updated 2015-02-11

No results posted yet for this study

Summary

The purpose of this study is to identify eyes that show worsening and disease progression (progressor phenotypes).

Conditions

Sponsors & Collaborators

  • European Vision Institute Clinical Research Network

    lead NETWORK

Principal Investigators

  • José Cunha-Vaz, MD PhD · Association for Innovation and Biomedical Research on Light and Image

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-10-31

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01145599 on ClinicalTrials.gov